United States of America
Peter joined the board of Alliance in February 2010 following the acquisition of Cambridge Laboratories, where he spent five years, latterly as UK Commercial Director. With over 17 years industry experience, he has also served as a Board Member of the Association of the British Pharmaceutical Industry ("ABPI"). Prior to joining Cambridge Laboratories, Peter spent six years at GlaxoSmithKline. He holds an honours degree in Pharmacology from the University of Edinburgh.